The government is persisting with a way of buying hugely expensive medical devices that has been proven ineffective.
Pharmac has failed to deliver many savings and has yet to set up a way to technologically assess medical devices, even the high-risk and high-cost ones, despite 10 years of trying.
Phil Pennington reports.
